Search - tctmd.com

Displaying 1 - 20 of 51

Sort: Relevancy | Date

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

March 30, 2026

What’s Going to Be Hot at ACC 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

ESC/EACTS Release New Valvular Heart Disease Guidelines

News Conference News ESC 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

Yael L. Maxwell

September 03, 2025

Solid, Early Surgical Results With Polymer Mitral Valve

News Conference News NY Valves 2025

Solid, Early Surgical Results With Polymer Mitral Valve

July 02, 2025

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

News Conference News PCR London Valves 2024

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Michael O'Riordan

December 05, 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

News Conference News NY Valves 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Michael O'Riordan

June 10, 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

News Conference News TVT 2023

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Michael O'Riordan

June 13, 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

News Conference News TVT 2023

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Michael O'Riordan

June 09, 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

March 20, 2023

Surgeons ‘Implore’ Colleagues to Learn TEER Lest They Become ‘Dinosaurs’

News Conference News STS 2023

Surgeons ‘Implore’ Colleagues to Learn TEER Lest They Become ‘Dinosaurs’

Yael L. Maxwell

February 02, 2023

Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World

News Conference News AHA 2022

Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World

Michael O'Riordan

November 10, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

Pascal TEER Device Performs Well in Patients With Complex Anatomy

News Conference News TCT 2022

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Yael L. Maxwell

September 26, 2022

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

News Conference News TCT 2022

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

Yael L. Maxwell

September 23, 2022

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

News Conference News TCT 2022

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Yael L. Maxwell

September 17, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.